Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
作者信息
Maistrello I, Grassi G, Bertolino A, Valerio P, Pistollato G, Soverini S
出版信息
Adv Biochem Psychopharmacol. 1982;32:369-73.
PMID:7090902
Abstract
摘要
相似文献
1
Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
Adv Biochem Psychopharmacol. 1982;32:369-73.
2
[Clinico-experimental data on the efficacy of viloxazine in depressive states].
Rev Med Chir Soc Med Nat Iasi. 1988 Jan-Mar;92(1):49-52.
3
Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
Adv Biochem Psychopharmacol. 1982;32:113-20.
4
A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
Int J Clin Pharmacol Ther Toxicol. 1985 May;23(5):270-3.
5
Clinical pharmacology of viloxazine hydrochloride.
Pharmacopsychiatria. 1981 Mar;14(2):66-70. doi: 10.1055/s-2007-1019568.
6
Multicentre study with viloxazine (Vivalan) in depressed patients.
Int Pharmacopsychiatry. 1980;15(4):228-39. doi: 10.1159/000468442.
7
Alcoholism and depression: a placebo controlled study with viloxazine.酒精成瘾与抑郁症：一项使用维洛沙嗪的安慰剂对照研究。
Int J Clin Pharmacol Res. 1990;10(5):293-8.
8
[Clinical trials of viloxazine in depressive states].
Encephale. 1979;5(3):243-9.
9
[Long-term tolerance of viloxazine].[维洛沙嗪的长期耐受性]
Encephale. 1982;8(4):511-21.
10
Do have antidepressants of the second generation anxiolytic properties?第二代抗抑郁药具有抗焦虑特性吗？
Agressologie. 1981 Nov;22(E):11-3.
Zotero 插件